EDITORIALS

Using Practice Guidelines to Assess Cancer Care Quality

Peter B. Bach

JCO Dec 20 2005: 9041–9043. First published on Nov 21 2005; 10.1200/JCO.2005.03.6111. [Full Text] [PDF]

Epidermal Growth Factor Receptor Inhibitors in Lung Cancer: Smaller or Larger Molecules, Selected or Unselected Populations?

Fred R. Hirsch and Paul A. Bunn, Jr

JCO Dec 20 2005: 9044–9047. First published on Nov 21 2005; 10.1200/JCO.2005.03.6129. [Full Text] [PDF]

The Epothilone Dilemma

Maja de Jonge and Jaap Verweij

JCO Dec 20 2005: 9048–9050. First published on Nov 21 2005; 10.1200/JCO.2005.03.8844. [Full Text] [PDF]

Mechanisms of Late Cardiovascular Toxicity From Cancer Chemotherapy

Richard Steingart

JCO Dec 20 2005: 9051–9052. First published on Nov 21 2005; 10.1200/JCO.2005.04.1731. [Full Text] [PDF]

Standards for Reporting Prognostic Tumor Marker Studies

Todd A. Alonzo

JCO Dec 20 2005: 9053–9054. First published on Nov 21 2005; 10.1200/JCO.2005.04.3778. [Full Text] [PDF]

Pediatric Palliative Care: Relationships Matter and So Does Pain Control

Mildred Z. Solomon and David Browning

JCO Dec 20 2005: 9055–9057. First published on Nov 28 2005; 10.1200/JCO.2005.04.4677. [Full Text] [PDF]

The Chemotherapy/Radiation Balance in Advanced Hodgkin's Lymphoma: Overweight Which Side?

Patrice Carde

JCO Dec 20 2005: 9058–9062. First published on Nov 28 2005; 10.1200/JCO.2005.04.4644. [Full Text] [PDF]

Improving Long-Term Outcomes for Patients With Liver Metastases From Colorectal Cancer

Geoffrey Chong and David Cunningham

JCO Dec 20 2005: 9063–9066. First published on Nov 21 2005; 10.1200/JCO.2005.04.4669. [Full Text] [PDF]

COMMENTS AND CONTROVERSIES

Reporting Recommendations for Tumor Marker Prognostic Studies

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, and Gary M. Clark

JCO Dec 20 2005: 9067–9072. First published on Sep 19 2005; 10.1200/JCO.2004.01.0454. [Full Text] [PDF]

Neoadjuvant Chemotherapy for Metastatic Colon Cancer: A Cautionary Note

Anton J. Bilchik, Graeme Poston, Steven A. Curley, Steven Strasberg, Leonard Saltz, Rene Adam, Bernard Nordlinger, Philippe Rougier, and Lee S. Rosen

JCO Dec 20 2005: 9073–9078. [Full Text] [PDF]

ORIGINAL REPORTS
Statistical/Economic Analysis
	Insurance Status and the Use of Guideline Therapy in the Treatment of Selected Cancers
	Linda C. Harlan, Amanda L. Greene, Limin X. Clegg, Margaret Mooney, Jennifer L. Stevens, and Martin L. Brown
	JCO Dec 20 2005: 9079–9088. First published on Nov 21 2005; 10.1200/JCO.2004.00.1297. [Abstract] [Full Text] [PDF]

Lung Cancer
	Phase I/IIa Study of Cetuximab With Gemcitabine Plus Carboplatin in Patients With Chemotherapy-Naïve Advanced Non–Small-Cell Lung Cancer
	Francisco Robert, George Blumenschein, Roy S. Herbst, Frank V. Fossella, Jennifer Tseng, Mansoor N. Saleh, and Michael Needle
	JCO Dec 20 2005: 9089–9096. First published on Nov 21 2005; 10.1200/JCO.2004.00.1438. [Abstract] [Full Text] [PDF]
	Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003
	Stephen K. Williamson, John J. Crowley, Primo N. Lara, Jr, Jason McCoy, Derick H.M. Lau, Robert W. Tucker, Glenn M. Mills, and David R. Gandara
	JCO Dec 20 2005: 9097–9104. [Abstract] [Full Text] [PDF]
	14-3-3 Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group
	José Luis Ramirez, Rafael Rosell, Miquel Taron, Maria Sanchez-Ronco, Vicente Alberola, Ramon de las Peñas, José Miguel Sanchez, Teresa Moran, Carlos Camps, Bartomeu Massuti, José Javier Sanchez, Fernanda Salazar, and Silvia Catot
	JCO Dec 20 2005: 9105–9112. [Abstract] [Full Text] [PDF]
	Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group
	Aminah Jatoi, Shauna Hillman, Philip Stella, Erin Green, Alex Adjei, Suresh Nair, Edith Perez, Bipinkur Amin, Steven E. Schild, Rene Castillo, and James R. Jett
	JCO Dec 20 2005: 9113–9119. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Phase I Dose-Finding Study of Weekly Single-Agent Patupilone in Patients With Advanced Solid Tumors
	Eric H. Rubin, John Rothermel, Fisseha Tesfaye, Tianling Chen, Martine Hubert, Yu-Yun Ho, Chyi-Hung Hsu, and Amit M. Oza
	JCO Dec 20 2005: 9120–9129. First published on Nov 21 2005; 10.1200/JCO.2005.03.0981. [Abstract] [Full Text] [PDF]

Treatment-Related Complications
	Acute Chemotherapy-Induced Cardiovascular Changes in Patients With Testicular Cancer
	Janine Nuver, Andries J. Smit, Jan van der Meer, Maarten P. van den Berg, Winette T.A. van der Graaf, Martin T. Meinardi, Dirk Th. Sleijfer, Harald J. Hoekstra, Anne I. van Gessel, Arie M. van Roon, and Jourik A. Gietema
	JCO Dec 20 2005: 9130–9137. First published on Nov 21 2005; 10.1200/JCO.2005.01.4092. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	High Telomerase RNA Expression Level Is an Adverse Prognostic Factor for Favorable-Histology Wilms' Tumor
	Jeffrey S. Dome, Carol A. Bockhold, Sierra M. Li, Scott D. Baker, Daniel M. Green, Elizabeth J. Perlman, D. Ashley Hill, and Norman E. Breslow
	JCO Dec 20 2005: 9138–9145. First published on Sep 19 2005; 10.1200/JCO.2005.00.562. [Abstract] [Full Text] [PDF]
	End-of-Life Care Preferences of Pediatric Patients With Cancer
	Pamela S. Hinds, Donna Drew, Linda L. Oakes, Maryam Fouladi, Sheri L. Spunt, Christopher Church, and Wayne L. Furman
	JCO Dec 20 2005: 9146–9154. First published on Sep 19 2005; 10.1200/JCO.2005.10.538. [Abstract] [Full Text] [PDF]
	Parent and Physician Perspectives on Quality of Care at the End of Life in Children With Cancer
	Jennifer W. Mack, Joanne M. Hilden, Jan Watterson, Caron Moore, Brian Turner, Holcombe E. Grier, Jane C. Weeks, and Joanne Wolfe
	JCO Dec 20 2005: 9155–9161. First published on Sep 19 2005; 10.1200/JCO.2005.04.010. [Abstract] [Full Text] [PDF]
	Care-Related Distress: A Nationwide Study of Parents Who Lost Their Child to Cancer
	Ulrika Kreicbergs, Unnur Valdimarsdóttir, Erik Onelöv, Olle Björk, Gunnar Steineck, and Jan-Inge Henter
	JCO Dec 20 2005: 9162–9171. First published on Sep 19 2005; 10.1200/JCO.2005.08.557. [Abstract] [Full Text] [PDF]
	Risk Factors and Therapy for Isolated Central Nervous System Relapse of Pediatric Acute Myeloid Leukemia
	Donna L. Johnston, Todd A. Alonzo, Robert B. Gerbing, Beverly J. Lange, and William G. Woods
	JCO Dec 20 2005: 9172–9178. [Abstract] [Full Text] [PDF]
	Phase I Clinical and Pharmacokinetic Study of Flavopiridol in Children With Refractory Solid Tumors: A Children's Oncology Group Study
	James A. Whitlock, Mark Krailo, Joel M. Reid, Stacie L. Ruben, Matthew M. Ames, William Owen, and Gregory Reaman
	JCO Dec 20 2005: 9179–9186. [Abstract] [Full Text] [PDF]
	Health Insurance Coverage in Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
	Elyse R. Park, Frederick P. Li, Yan Liu, Karen M. Emmons, Arthur Ablin, Leslie L. Robison, and Ann C. Mertens
	JCO Dec 20 2005: 9187–9197. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano Linfomi
	Paolo G. Gobbi, Alessandro Levis, Teodoro Chisesi, Chiara Broglia, Umberto Vitolo, Caterina Stelitano, Vincenzo Pavone, Luigi Cavanna, Gino Santini, Francesco Merli, Marina Liberati, Luca Baldini, Giorgio Lambertenghi Deliliers, Emanuele Angelucci, Roberto Bordonaro, and Massimo Federico
	JCO Dec 20 2005: 9198–9207. First published on Sep 19 2005; 10.1200/JCO.2005.02.907. [Abstract] [Full Text] [PDF]
	Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)
	Peter W.M. Johnson, John A. Radford, Michael H. Cullen, Matthew R. Sydes, Jan Walewski, Andrew S. Jack, Kenneth A. MacLennan, Sally P. Stenning, Simon Clawson, Paul Smith, David Ryder, and Barry W. Hancock
	JCO Dec 20 2005: 9208–9218. First published on Nov 28 2005; 10.1200/JCO.2005.03.2151. [Abstract] [Full Text] [PDF]
	Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party
	Bradley M. Augustson, Gulnaz Begum, Janet A. Dunn, Nicola J. Barth, Faith Davies, Gareth Morgan, Judith Behrens, Alastair Smith, J. Anthony Child, and Mark T. Drayson
	JCO Dec 20 2005: 9219–9226. First published on Nov 7 2005; 10.1200/JCO.2005.03.2086. [Abstract] [Full Text] [PDF]
	High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe
	Jean-Paul Fermand, Sandrine Katsahian, Marine Divine, Veronique Leblond, Francois Dreyfus, Margaret Macro, Bertrand Arnulf, Bruno Royer, Xavier Mariette, Edouard Pertuiset, Coralie Belanger, Maud Janvier, Sylvie Chevret, Jean Claude Brouet, and Philippe Ravaud
	JCO Dec 20 2005: 9227–9233. First published on Nov 7 2005; 10.1200/JCO.2005.03.0551. [Abstract] [Full Text] [PDF]
	Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study
	Guido Marcucci, Claudia D. Baldus, Amy S. Ruppert, Michael D. Radmacher, Krzysztof Mrózek, Susan P. Whitman, Jonathan E. Kolitz, Colin G. Edwards, James W. Vardiman, Bayard L. Powell, Maria R. Baer, Joseph O. Moore, Danilo Perrotti, Michael A. Caligiuri, Andrew J. Carroll, Richard A. Larson, Albert de la Chapelle, and Clara D. Bloomfield
	JCO Dec 20 2005: 9234–9242. First published on Nov 7 2005; 10.1200/JCO.2005.03.6137. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study
	Steven R. Alberts, William L. Horvath, William C. Sternfeld, Richard M. Goldberg, Michelle R. Mahoney, Shaker R. Dakhil, Ralph Levitt, Kendrith Rowland, Suresh Nair, Daniel J. Sargent, and John H. Donohue
	JCO Dec 20 2005: 9243–9249. First published on Oct 17 2005; 10.1200/JCO.2005.07.740. [Abstract] [Full Text] [PDF]
	Docetaxel Plus Gemcitabine or Docetaxel Plus Cisplatin in Advanced Pancreatic Carcinoma: Randomized Phase II Study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group
	Manfred P. Lutz, Eric Van Cutsem, Theo Wagener, Jean-Luc Van Laethem, Udo Vanhoefer, Jacques A. Wils, Eric Gamelin, Claus H. Koehne, Jean P. Arnaud, Emmanuel Mitry, Faress Husseini, Peter Reichardt, Mustafa El-Serafi, Pierre-Luc Etienne, Thomas Lingenfelser, Michel Praet, Bruno Genicot, Muriel Debois, Bernard Nordlinger, and Michel P. Ducreux
	JCO Dec 20 2005: 9250–9256. [Abstract] [Full Text] [PDF]
	Low Rectal Cancer: A Call for a Change of Approach in Abdominoperineal Resection
	Iris D. Nagtegaal, Cornelius J.H. van de Velde, Corrie A.M. Marijnen, Jan H.J.M. van Krieken, and Philip Quirke
	JCO Dec 20 2005: 9257–9264. [Abstract] [Full Text] [PDF]
	Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma
	Mace L. Rothenberg, Bonnie LaFleur, Donna E. Levy, Mary Kay Washington, Sherry L. Morgan-Meadows, Ramesh K. Ramanathan, Jordan D. Berlin, Al B. Benson, III, and Robert J. Coffey
	JCO Dec 20 2005: 9265–9274. [Abstract] [Full Text] [PDF]

Clinical Trials
	Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials
	Michelle R. Mahoney, Daniel J. Sargent, Michael J. O'Connell, Richard M. Goldberg, Paul Schaefer, and Jan C. Buckner
	JCO Dec 20 2005: 9275–9281. [Abstract] [Full Text] [PDF] [Publisher's Note]
	Evaluation of Factors Affecting Awareness of and Willingness to Participate in Cancer Clinical Trials
	Primo N. Lara, Jr, Debora A. Paterniti, Christine Chiechi, Corinne Turrell, Claudia Morain, Nora Horan, Lisa Montell, Jose Gonzalez, Sharon Davis, Ari Umutyan, Cynthia L. Martel, David R. Gandara, Ted Wun, Laurel A. Beckett, and Moon S. Chen, Jr
	JCO Dec 20 2005: 9282–9289. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell Tumors
	G. Varuni Kondagunta, Jennifer Bacik, Dean Bajorin, Deborah Dobrzynski, Joel Sheinfeld, Robert J. Motzer, and George J. Bosl
	JCO Dec 20 2005: 9290–9294. [Abstract] [Full Text] [PDF]

Breast Cancer
	Dietary Patterns and Survival After Breast Cancer Diagnosis
	Candyce H. Kroenke, Teresa T. Fung, Frank B. Hu, and Michelle D. Holmes
	JCO Dec 20 2005: 9295–9303. [Abstract] [Full Text] [PDF]
	Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy
	Bryan T. Hennessy, Gabriel N. Hortobagyi, Roman Rouzier, Henry Kuerer, Nour Sneige, Aman U. Buzdar, Shu Wan Kau, Bruno Fornage, Aysegul Sahin, Kristine Broglio, S. Eva Singletary, and Vicente Valero
	JCO Dec 20 2005: 9304–9311. [Abstract] [Full Text] [PDF]
	Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes
	Matthew P. Goetz, James M. Rae, Vera J. Suman, Stephanie L. Safgren, Matthew M. Ames, Daniel W. Visscher, Carol Reynolds, Fergus J. Couch, Wilma L. Lingle, David A. Flockhart, Zeruesenay Desta, Edith A. Perez, and James N. Ingle
	JCO Dec 20 2005: 9312–9318. [Abstract] [Full Text] [PDF]
	Individualized Survival Curves Improve Satisfaction With Cancer Risk Management Decisions in Women With BRCA1/2 Mutations
	Katrina Armstrong, Barbara Weber, Peter A. Ubel, Nikki Peters, John Holmes, and J. Sanford Schwartz
	JCO Dec 20 2005: 9319–9328. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651–Gynecologic Oncology Group 183
	Hedvig Hricak, Constantine Gatsonis, Dennis S. Chi, Marco A. Amendola, Kathy Brandt, Lawrence H. Schwartz, Susan Koelliker, Evan S. Siegelman, Jeffrey J. Brown, Robert B. McGhee, Jr, Revathy Iyer, Kenneth M. Vitellas, Bradley Snyder, Harry J. Long, III, James V. Fiorica, and Donald G. Mitchell
	JCO Dec 20 2005: 9329–9337. [Abstract] [Full Text] [PDF]
	Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels Within the Normal Range
	Antonio Santillan, Ruchi Garg, Marianna L. Zahurak, Ginger J. Gardner, Robert L. Giuntoli, II, Deborah K. Armstrong, and Robert E. Bristow
	JCO Dec 20 2005: 9338–9343. [Abstract] [Full Text] [PDF]
	Women With Synchronous Primary Cancers of the Endometrium and Ovary: Do They Have Lynch Syndrome?
	Pamela T. Soliman, Russell R. Broaddus, Kathleen M. Schmeler, Molly S. Daniels, Delia Gonzalez, Brian M. Slomovitz, David M. Gershenson, and Karen H. Lu
	JCO Dec 20 2005: 9344–9350. [Abstract] [Full Text] [PDF]

Melanoma
	Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy
	Takuji Mori, Steven J. O’Day, Naoyuki Umetani, Steve R. Martinez, Minoru Kitago, Kazuo Koyanagi, Christine Kuo, Teh-Ling Takeshima, Robert Milford, He-Jing Wang, Vu D. Vu, Sandy L. Nguyen, and Dave S.B. Hoon
	JCO Dec 20 2005: 9351–9358. [Abstract] [Full Text] [PDF]

Neurooncology
	Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme
	David A. Reardon, Merrill J. Egorin, Jennifer A. Quinn, Jeremy N. Rich, Sr, Idharan Gururangan, James J. Vredenburgh, Annick Desjardins, Sith Sathornsumetee, James M. Provenzale, James E. Herndon, II, Jeannette M. Dowell, Michael A. Badruddoja, Roger E. McLendon, Theodore F. Lagattuta, Kimberly P. Kicielinski, Gregor Dresemann, John H. Sampson, Allan H. Friedman, August J. Salvado, and Henry S. Friedman
	JCO Dec 20 2005: 9359–9368. [Abstract] [Full Text] [PDF]

Sarcomas
	MYC Amplification and Polysomy 8 in Chondrosarcoma: Array Comparative Genomic Hybridization, Fluorescent In Situ Hybridization, and Association With Outcome
	Carl Morrison, Michael Radmacher, Nehad Mohammed, David Suster, Herbert Auer, Susie Jones, Judy Riggenbach, Nicole Kelbick, Gary Bos, and Joel Mayerson
	JCO Dec 20 2005: 9369–9376. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Efficacy and Safety Analysis of Epoetin Alfa in Patients With Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
	Thomas Grote, Allen L. Yeilding, Rene Castillo, Dean Butler, Ellioth Fishkin, David H. Henry, Michael DeLeo, Kenneth Fink, and Daniel J. Sullivan
	JCO Dec 20 2005: 9377–9386. [Abstract] [Full Text] [PDF]

Bone Marrow Transplantation
	Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
	Sudhir Tauro, Charles Craddock, Karl Peggs, Gulnaz Begum, Premini Mahendra, Gordon Cook, Judith Marsh, Donald Milligan, Anthony Goldstone, Ann Hunter, Asim Khwaja, Raj Chopra, Timothy Littlewood, Andrew Peniket, Anne Parker, Graham Jackson, Geoff Hale, Mark Cook, Nigel Russell, and Stephen Mackinnon
	JCO Dec 20 2005: 9387–9393. First published on Nov 28 2005; 10.1200/JCO.2005.02.0057. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Targeted Induction of Apoptosis in Cancer Management: The Emerging Role of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Activating Agents
	Eric K. Rowinsky
	JCO Dec 20 2005: 9394–9407. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Targeting the Cell Cycle: A New Approach to Cancer Therapy
	Gary K. Schwartz and Manish A. Shah
	JCO Dec 20 2005: 9408–9421. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Symptoms in Cancer Patients and an Unusual Tumor: CASE 1. Regression of Hypertrophic Pulmonary Osteoarthropathy Following Chemotherapy for Lung Metastases of a Nasopharyngeal Carcinoma

Ayhan Ulusakarya, Yusuf Gumus, Nacera Brahimi, Béatrice Delmas-Marsalet, Wathek Almohamad, Srimanta C. Misra, Emma Goldschmidt, Mazen Haydar, and David Machover

JCO Dec 20 2005: 9422–9423. [Full Text] [PDF]

Symptoms in Cancer Patients and an Unusual Tumor: CASE 2. Docetaxel-Related Ischemic Colitis

M.A. Hafiz Hussein, Brian R. Bird, Martin J. O’Sullivan, Sri Ganesh Kalimuthu, Gerald C. O’Sullivan, Seamus O’Reilly, and Oscar S. Breathnach

JCO Dec 20 2005: 9424–9425. [Full Text] [PDF]

Symptoms in Cancer Patients and an Unusual Tumor: CASE 3. Follicular Dendritic Cell Sarcoma

Tania Khalid and Robert Folman

JCO Dec 20 2005: 9425–9426. [Full Text] [PDF]

CORRESPONDENCE

Calculation of Survival of Patients With Stage III Melanoma

David Berd, Michael J. Mastrangelo, and Takami Sato

JCO Dec 20 2005: 9427. [Full Text] [PDF]

In Reply:

Charles M. Balch, Seng-Jaw Soong, and Renee Desmond

JCO Dec 20 2005: 9428. [Full Text] [PDF]

Misleading Statements in Industry-Sponsored Meta-Analysis of Itraconazole

Peter C. Gøtzsche and Helle Krogh Johansen

JCO Dec 20 2005: 9428-a–9429. [Full Text] [PDF]

In Reply:

Axel Glasmacher, Archibald Prentice, Marcus Gorschlüter, Steffen Engelhart, Corinna Hahn, Benjamin Djulbegovic, and Ingo G.H. Schmidt-Wolf

JCO Dec 20 2005: 9429–9432. [Full Text] [PDF]

Bone Loss With Exemestane: Is the Jury Still Out?

Angela M. Cheung, George Tomlinson, and Paul E. Goss

JCO Dec 20 2005: 9433–9434. [Full Text] [PDF]

In Reply:

Per Eystein Lønning and Jurgen Geisler

JCO Dec 20 2005: 9434–9435. [Full Text] [PDF]

Treatment Guidelines for Adjuvant Breast Cancer Are Moving Toward Double Standards: One for the Rich and One for the Poor

Gaston Demonty

JCO Dec 20 2005: 9436–9437. [Full Text] [PDF]

In Reply:

Francesco Boccardo and Alessandra Rubagotti

JCO Dec 20 2005: 9437–9439. [Full Text] [PDF]

Validation of Microarray Data by Quantitative Reverse-Transcriptase Polymerase Chain Reaction

Serge Koscielny, Stefan Michiels, Valérie Boige, and Catherine Hill

JCO Dec 20 2005: 9439–9440. [Full Text] [PDF]

In Reply:

Enrique Espinosa, Juan Ángel Fresno Vara, Andrés Redondo, and José Javier Sánchez

JCO Dec 20 2005: 9440. [Full Text] [PDF]

Overall Survival of Patients With Advanced Colorectal Cancer Correlates With Availability of Fluorouracil, Irinotecan, and Oxaliplatin Regardless of Whether Doublet or Single-Agent Therapy Is Used First Line

Axel Grothey and Daniel Sargent

JCO Dec 20 2005: 9441–9442. [Full Text] [PDF]

Randomized Phase II Studies and Their Ethics

Raymond P. Abratt, William H.H. Reece, Nathan H. Enas, and Richard Stephens

JCO Dec 20 2005: 9443. [Full Text] [PDF]

Time to Re-Evaluate Sentinel Node Biopsy in Melanoma Post-Multicenter Selective Lymphadenectomy Trial

Joseph Meirion Thomas

JCO Dec 20 2005: 9443-a–9444. [Full Text] [PDF]

ERRATA

ERRATA

JCO Dec 20 2005: 9445. [Full Text] [PDF]

ERRATA

JCO Dec 20 2005: 9445-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.